home / lobbying / lobbying_activities

lobbying_activities: 994632

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id filing_uuid filing_type registrant_name registrant_id client_name filing_year filing_period issue_code specific_issues government_entities income_amount expense_amount is_no_activity is_termination received_date
994632 64a16210-d452-407c-af06-7ea711527f3f Q3 PURDUE PHARMA, LP 81214 PURDUE PHARMA LP 2010 third_quarter CPT H.R.756/S.660 National Pain Care Policy Act of 2009 H.R.1191/S. 1336 Safe Drug Disposal Act of 2009 H.R.1260/S.515/S.610 Patent Reform Act of 2009 H.R.1298/S.525 Pharmaceutical Market Access and Drug Safety Act of 2009 H.R.1359/S.1292 Secure and Responsible Drug Disposal Act of 2009 H.R.1427/S.726 Promoting Innovation and Access to Life-Saving Medicine Act H.R.1548 Pathway for Biosimilars Act H.R.1706 Protecting Consumer Access to Generic Drugs Act of 2009 H.R.3200 America's Affordable Health Choices Act of 2009 H.R.3590 Patient Protection and Affordable Care Act H.R.3962 Affordable Health Care for America Act H.R.4872 Health Care and Education Reconciliation Act of 2010 H.R.4956 Stop Oxy Abuse Act of 2010 H.R.5712 VeteranS', Seniors', and Children's Health Technical Corrections Act of 2010 H.R.5809/S.3397Safe Drug Disposal/Secure and Responsible Drug Disposal Act of 2010 H.R.6165 Life Sciences Jobs and Investment Act of 2010 S.301 Physician Payments Sunshine Act of 2009 S.369 Preserve Access to Affordable Generics Act of 2009 S.1796 America's Healthy Future Act of 2009 Anti- counterfeiting legislation concerning drugs (pedigree) Biosimilar Drugs Disposal of Drugs Drug Reimportation Healthcare Reform Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation Prescription Drug User Fee Act reauthorization RiskEvaluation and MitigationStrategies for controlled substances Tax on pharmaceutical companies (Senate Finance Committee draft of health care reform) Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   240000 0 0 2010-10-15T13:57:12.830000-04:00
Powered by Datasette · Queries took 0.41ms · Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API